<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/news" routerlinkactive="active" class="nav-link" href="/news">News</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">About GARD</a><a routerlink="/espanol" routerlinkactive="active" class="nav-link" href="/espanol">En Espan√µl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 7674 - Spinal muscular atrophy</h1></div><div><p><b>Other Names: </b>SMA</p><p><b>Categories: </b><!----></p><p><b>This disease is grouped under: </b>Spinal muscular atrophy 1</p><p><b>Summary: </b><span>Spinal muscular atrophy (SMA) is a group of genetic neuromuscular disorders that affect the nerve cells that control voluntary muscles (motor neurons). The loss of motor neurons causes progressive muscle weakness and loss of movement due to muscle wasting (atrophy). The severity of the symptoms, the age at which symptoms,&nbsp; begin, and genetic cause varies by type. Many types of SMA mainly affect the muscles involved in walking, sitting, arm movement, and head control. Breathing and swallowing may also become difficult as the disease progresses in many types of SMA. In some types of SMA, the loss of motor neurons makes it hard to control movement of the hands and feet.[2299][2300][2302] <br>
<br>
SMA type 1, 2, 3, and 4 are caused by changes (pathogenic variants, also know as mutations) in the <em><a href="http://ghr.nlm.nih.gov/gene/SMN1" tabindex="-1" target="_blank">SMN1</a></em> gene and are inherited in an autosomal recessive manner. Extra copies of the nearby related gene, <em><a href="http://ghr.nlm.nih.gov/gene/SMN2" tabindex="-1" target="_blank">SMN2</a>,</em> modify the severity of SMA. There are other rarer types of SMA caused by changes in different genes. Other autosomal recessive forms include&nbsp;<a href="https://ghr.nlm.nih.gov/condition/spinal-muscular-atrophy-with-progressive-myoclonic-epilepsy" target="_blank">SMA with progressive myoclonic epilepsy</a> (SMA-PME) caused by changes in the&nbsp;<em><a href="https://ghr.nlm.nih.gov/gene/ASAH1" target="_blank">ASAH1</a></em> gene and <a href="https://ghr.nlm.nih.gov/condition/spinal-muscular-atrophy-with-respiratory-distress-type-1" target="_blank">SMA with respiratory distress 1</a> (SMARD1) caused by changes in the <em><a href="https://ghr.nlm.nih.gov/gene/IGHMBP2" target="_blank">IGHMBP2</a></em> gene. Autosomal dominant forms include <a href="https://ghr.nlm.nih.gov/condition/distal-hereditary-motor-neuropathy-type-v" target="_blank">distal MSA type V</a> &nbsp;(DSMA-V) caused by changes in&nbsp;<a href="https://ghr.nlm.nih.gov/gene/BSCL2" target="_blank"><em>BSCL2</em></a> and <em><a href="https://ghr.nlm.nih.gov/gene/GARS" target="_blank">GARS</a></em>, <a href="https://ghr.nlm.nih.gov/condition/spinal-muscular-atrophy-with-lower-extremity-predominance" target="_blank">SMA with lower extremity predominance</a> (SMA-LED) caused by changes in  <em><a href="http://ghr.nlm.nih.gov/gene/DYNC1H1" tabindex="-1" target="_blank">DYNC1H1</a> or </em><em><a href="https://ghr.nlm.nih.gov/gene/BICD2" target="_blank">BICD2</a></em>, and adult-onset form of SMA caused changes by <em><a href="http://ghr.nlm.nih.gov/gene/VAPB" tabindex="-1" target="_blank">VAPB</a></em>.&nbsp;<a href="http://www.genome.gov/Glossary/index.cfm?id=209" tabindex="-1" target="_blank"> X-linked</a> forms include <a href="https://www.ncbi.nlm.nih.gov/books/NBK1333/" target="_blank">X-linked infantile SMA</a> caused by changes in <em><a href="http://ghr.nlm.nih.gov/gene/UBA1" tabindex="-1" target="_blank">UBA1</a></em>.[2301] <br>
<br>
Diagnosis of SMA is suspected by symptoms and confirmed by genetic testing. Treatments are in general supportive aiming to increase quality of life and avoid complications. Treatments may include physical therapy, nutrition support, <a href="https://www.merckmanuals.com/home/lung-and-airway-disorders/rehabilitation-for-lung-and-airway-disorders/chest-physical-therapy" target="_blank">chest physiotherapy</a>, and, in severe cases, breathing machines (<a href="https://medlineplus.gov/ency/patientinstructions/000458.htm" target="_blank">ventilators</a>).[14883][14884] In December 2016, <a href="https://medlineplus.gov/druginfo/meds/a617010.html" target="_blank">nusinersen</a> (Spinraza) became the first FDA approved treatment for SMA types 1, 2, 3, and 4. Continued treatment with nusinersen has been shown to slow the progression of the disease and even improve muscle function, but individual response to the treatment does vary.[14885][14886] &nbsp;Due to the success of nusinersen as well as other promising treatments presently in clinical trials,&nbsp;<span>SMA caused by changes in the&nbsp;<em>SMN1</em>&nbsp;gene has been added to the list of recommended newborn screening</span><span>&nbsp;tests in the United States, so that  treatment may begin before symptoms develop. However, <span>as of July 2018,&nbsp;</span>not all States have added the test to their newborn screening panel.[14910]</span></span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Cure SMA</a></span><br><span>925 Busse Road</span><br><span>Elk Grove IL, 60007</span><br><!----><!----></li><li><span><a href="org.url">Spinal Muscular Atrophy Foundation</a></span><br><span>888 Seventh Avenue</span><br><span>New York NY, 10019</span><br><!----><!----></li><li><span><a href="org.url">Muscular Dystrophy Association</a></span><br><span>222 S Riverside Plaza</span><br><span>Chicago IL, 60606</span><br><!----><!----></li><li><span><a href="org.url">SMA Gruba</a></span><br><!----></li><li><span><a href="org.url">SMA Europe</a></span><br><!----></li><li><span><a href="org.url">Spinal Muscular Atrophy Association of Australia Inc.</a></span><br><span>PO Box 5245 (mail)</span><br><span>Hallam Vic , 3803</span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Spinal%20muscular%20atrophy%5Btitle%5D%20AND%20hasabstract%5Btext%5D&amp;cmd=DetailsSearch" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Spinal muscular atrophy. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Spinal+muscular+atrophy%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Spinal muscular atrophy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span><a href="http://ghr.nlm.nih.gov/condition=spinalmuscularatrophy" target="_blank">Genetics Home Reference (GHR)</a> contains information on Spinal muscular atrophy. This website is maintained by the National Library of Medicine.<br>
</span></li><li><span>The <a href="http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1135/viewAbstract" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000996.htm" target="_blank">MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
<br>
</span></li><li><span>The <a href="https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Spinal-Muscular-Atrophy-Fact-Sheet" target="_blank">National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.</span></li><li><span><a href="http://emedicine.medscape.com/article/1181436-overview" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=sma" target="_blank">GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br>
</span></li><li><span>The <a href="http://projectreporter.nih.gov/reporter.cfm" target="_blank">Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the "Text Search" box.  Then click "Submit Query".</span></li><li><span>The <a href="http://www.genome.gov/20519681" target="_blank">National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.</span></li><li><span>The <a href="https://monarchinitiative.org/disease/OMIM:253400" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch‚Äôs tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><li><span><a href="http://events.curesma.org/site/PageNavigator/SmartMoves/SMArtMoves.html" target="_blank">SMArt Moves</a>,&nbsp;a disease awareness and educational campaign launched by&nbsp;<a href="http://www.curesma.org/" target="_blank">Cure SMA</a>, provides resources for&nbsp;parents, pediatricians and other healthcare professionals to promptly recognize and diagnose the early signs of spinal muscular atrophy (SMA). SMArt Moves&nbsp;has an <a href="http://www.curesma.org/documents/research-documents/smart-moves-toolkit.pdf" target="_blank">SMA Diagnostic Toolkit</a> to help healthcare professionals recognize SMA in their patients.</span></li><li><span><a href="http://www.curesma.org/sma/about-sma/" target="_blank">Cure SMA</a>, an organization dedicated to the treatment of SMA and providing families with support, provides information about the types, causes and diagnosis of SMA.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/">NCATS Home</a></div><div class="col"><a href="javascript: void(0)">Site Map</a></div><div class="col"><a href="javascript: void(0)">Browse Glossary A-Z</a></div><div class="col"><a href="javascript: void(0)">Privacy Notice</a></div><div class="col"><a href="javascript: void(0)">Disclaimer</a></div><div class="col"><a href="javascript: void(0)">Accessibility</a></div><div class="col"><a href="javascript: void(0)">FOIA </a></div><div class="col"><a href="javascript: void(0)">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>
<script src="runtime.e227d1a0e31cbccbf8ec.js" defer=""></script><script src="polyfills.1aefc75bf7d5acb269d2.js" defer=""></script><script src="main.f870601fdb5bc988c829.js" defer=""></script>
<script id="ScullyIO-transfer-state"></script><script src="js/custom.js"></script>

</body></html>